Detalhe da pesquisa
1.
Donor Immunization Against Human Leukocyte Class II Antigens is a Risk Factor for Graft-versus-Host Disease.
Biol Blood Marrow Transplant
; 22(2): 292-299, 2016 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-26453972